COL17A1 and cancer: Other forms of MMP include serotypes which produce antibodies against the different subunits of the α6β4-integrin heterodimer, which instead is thought to be linked to a decreased risk of cancer (15, 16), and a serotype with production of antibodies against BP180 and BP230 which seems to have no effect on cancer risk (12, 16).